Delivery Order SPE2DB20D2104-SPE2DB22FR32P
Award Date 12/21/21
Potential Completion Date 12/22/21
Potential Value $5.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract, valued at $4,321.92, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 20, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract, valued at $15,912.49, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 5, 2023. This is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion 60s to the Defense Logistics Agency (DLA). The contract, valued at $11,657.58, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and has a completion date of May 3, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $3,326.76 and a completion date of January 26, 2022. The award was made on January 25, 2022, and there was no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $8,729.62 and a completion date of October 20, 2021. The contract was awarded on October 19, 2021, and there was no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to support healthcare needs across the U.S. Department of Defense and other federal agencies. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) on October 12, 2021, with a ceiling value of $6,443.73. The contract is a firm-fixed price delivery order with an ultimate completion date of...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,482.88 and was awarded on June 6, 2022, with a completion date of June 7, 2022. The contract is a delivery order with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $1,967.14 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 5, 2022, with a completion date of May 6, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract, valued at $5,084.64, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a firm fixed-price and was awarded as a delivery order, with a completion date of August 13, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion from Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,320.58 delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of January 28, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...